Medtronic InFuse for cervical spine
This article was originally published in The Gray Sheet
Executive Summary
Firm will conduct a trial of its InFuse bone graft in cervical spinal fusion after being granted an investigational device exemption from FDA, Medtronic announces Oct. 13. The bone graft will be used inside a polyetheretherketone (PEEK) polymer interbody spacer with a cervical plate. According to Medtronic, 200,000 spinal fusion procedures for the cervical spine are conducted in the U.S. each year. InFuse is approved to treat open tibia fractures and for anterior lumbar interbody fusion procedures. The firm also is pursuing approval for InFuse in posterior lumbar fusion and oral maxillofacial procedures...